Searchable abstracts of presentations at key conferences in endocrinology

ea0090p73 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Paediatric Type 2 Diabetes in a single centre in East London in the period 2008-2018

Abdelhameed Farah , Giuffrida Anna , Thorp Ben , Moorthy Myuri , Gevers Evelien

Objective: Incidence of paediatric type 2 diabetes appears to be increasing. We describe our cohort of paediatric type 2 diabetes at Barts Health NHS Trust in East London (UK) over the period 2008-2018 to gain insight in incidence, complications and outcomes.Methods: Retrospective cohort study. Data collection from Twinkle (electronic database for diabetes) and paper notes.Results: Fourty patients (25 female) were diagnosed with T2...

ea0090ep73 | Adrenal and Cardiovascular Endocrinology | ECE2023

«Non-classical» pheochromocytoma, clinical case

Motrenko Anna , Gurevich Larisa , Britvin Timur , Ilovayskaya Irena

Neuroendocrine neoplasias (NENs) are a heterogeneous group of tumors that differ in appearance, growth patterns, and clinical symptoms and develop from neuroendocrine cells and, accordingly, unusually similar cytological characteristics. Pheochromocytoma is considered as not epithelial type of NENs. We would like to present a clinical case of pheochromocytoma with difficulties in laboratory diagnosis and morphological verification. Female patient P., 60 years old, for 10 years...

ea0090ep142 | Calcium and Bone | ECE2023

Chronic hypoparathyroidism: Predictors of complications according to the Russian Registry

Kovaleva Elena , Elfimova Alina , Eremkina Anna , Mokrysheva Natalia

Background: Chronic hypoparathyroidism is a relatively rare disease associated with various complications. The analysis of large databases of patients with chronic hypoparathyroidism is a necessary tool to enhance quality of medical care, as well as to determine the therapeutic approaches and prognostic markers of the disease.Aims: To describe complications associated with chronic hypoparathyroidism and determine predictors of their development according...

ea0090ep201 | Calcium and Bone | ECE2023

A Late Diagnosed Neurofibromatosis Case During Preoperative Evaluation For Scoliosis

Yazan Ceyda Dincer , Abbasgholizadeh Anna , Yavuz Dilek Gogas

Objective: Neurofibromatosis type 1 is an autosomal dominant inherited neurocutaneous condition characterized with multipl cafe-au-lait spots, neurofibromas, predisposition to malignancies, and the incidence of disease is 1:3000. Patients are diagnosed according to diagnostic criteria and 97% of the patents meet the criteria before 8 years of old. Diagnosis and follow-up of patients for manifestations of neurofibromatosis is important for early diagnosis and treatment of malig...

ea0090ep583 | Endocrine-related Cancer | ECE2023

Recurrent parathyroid cancer in a child associated with mutation in CDC73 gene

Kim Ekaterina , Krupinova Julia , Eremkina Anna , Kalinchenko Natalya , Mokrysheva Natalia

Background: Parathyroid cancer (P?) in children is extremely rare, more often sporadic, but may be associated with a germline mutation. The only effective treatment is surgical approach due to the chemo-radio-resistance of PC.Clinical case: A 6-years-old girl presented with weakness, gait disturbance, pain in the limbs, an X-shaped curvature of the legs. At the age of 12, the patient’s well-being worsened sharply. The laboratory examination revealed...

ea0090ep670 | Pituitary and Neuroendocrinology | ECE2023

Carney complex as a rare reason of acromegaly in adulthood

Perepelova Margarita , Przhiyalkovskaya Elena , Dzeranova Larisa , Pigarova Ekaterina , Kolodkina Anna

Carney complex is a rare hereditary syndrome with an autosomal dominant inheritance pattern that manifests itself with a set of specific symptoms. Case presentation. 32-year-old woman was admitted to the endocrinological hospital with an active stage of acromegaly. From the anamnesis it is known that at the age of 11, the height was 172 cm. The diagnosis of acromegaly was established at the age of 28 years: IGF-1 673.8 ng/ml (78–311), pituitary gland with para(d)-sellar s...

ea0090ep915 | Reproductive and Developmental Endocrinology | ECE2023

Genetic bases of hereditary gonadotropin-dependent precocious puberty

Kolodkina Anna , Khabibullina Dina , Bezlepkina Olga , Peterkova Valentina

Background: Nowadays, single nucleotide polymorphisms in genes KISS1, KISS1R, MKRN3, DLK1 have been described as the leading cause of precocious hypothalamic-pituitary axis activation in children. Genetic testing in patients with hereditary forms of precocious puberty (PP) can expand our knowledge in underlying molecular mechanisms of the disease. The diagnosis of genetic bases is necessary for genetic counselling.Aim: To access clinical charact...

ea0090ep1162 | Late Breaking | ECE2023

Can we predict medical treatment failure in Graves’ disease? 4-year follow-up data in a single centre

Leonidas Liarakos Alexandros , Foka Anna , Mohamed Ahmed , Kavvoura Foteini

Background: Graves’ disease (GD) is the commonest cause of primary hyperthyroidism in iodine-sufficient areas. First-line treatment is a 12-18 month course of anti-thyroid drugs (ATD). However, around 50% of GD patients will relapse, requiring further assessment and definitive treatment with radioactive iodine or thyroidectomy. Identifying risk factors that predict relapse or treatment failure after stopping ATD is important in guiding management. Several risk factors hav...

ea0065op2.2 | Thyroid | SFEBES2019

The SH2B3 tryptophan 262 variant is associated with Graves’ disease and Addison’s disease

Sneddon Georgina , Allinson Kathleen , Lane Laura , Mitchell Anna , Pearce Simon

Objective: The SH2B3 gene encodes the src homology-2B adaptor protein 3, also known as lymphocyte adaptor protein (LNK), and is a negative regulator of T lymphocyte activation and the cytokine signalling pathways involved in inflammation and haematopoiesis. rs3184504, a non-synonymous SNP (R262W) in exon 3 of the SH2B3 gene, has been associated with numerous autoimmune conditions including type 1 diabetes, rheumatoid arthritis and coeliac disease. Th...

ea0065p45 | Adrenal and Cardiovascular | SFEBES2019

An audit of the management of adults with Congenital Adrenal Hyperplasia in Newcastle upon Tyne – where are we now?

Devine Kerri , Pearce Simon , James Andy , Quinton Richard , Mitchell Anna

Background: Congenital adrenal hyperplasia (CAH) is the commonest genetic endocrine disorder, affecting 1 in 18 000 UK births. The 2010 CaHASE Study identified a myriad of health problems associated with CAH and its treatment, and a lack of consensus on treatment strategies in adults. Endocrine Society guidelines (2010, revised 2018) have since been published to support management. As one of the original CaHASE centres, we have audited our recent practice against these new sta...